Haiou Liu

17PUBLICATIONS
20CO-AUTHORS
Molecular targetsInnate immunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 17, 2025
Mannose Enhances Immunotherapy Efficacy in Ovarian Cancer by Modulating Gut Microbial Metabolites.

Chen Zhang, Yiying Wang, Mengdi He

|Mar 22, 2025
Immunosuppressive JAG2+ tumor-associated neutrophils hamper PD-1 blockade response in ovarian cancer by mediating the differentiation of effector regulatory T cells.

Chenyang Wang, Moran Yang, Yujing Zhong

|Feb 26, 2025
Targeting mesothelin-CD24 axis repolarizes tumor-associated macrophages to potentiate PD-1 blockade therapy in high-grade serous ovarian cancer.

Yujing Zhong, Yiying Wang, Chenyang Wang

|Oct 04, 2023
C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer.

Chen Zhang, Kankan Cao, Moran Yang

|Sep 14, 2023
Siglec-9+ tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer.

Yiying Wang, Mengdi He, Chen Zhang

|May 12, 2023
Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer.

Kankan Cao, Guodong Zhang, Moran Yang

Pageof 3

Frequent Collaborators

5 joint publications

Congjian Xu

5 joint publications

Mengdi He

4 joint publications

Moran Yang

4 joint publications

Yiying Wang